Sign up to save your podcasts
Or
Share Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 2
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies, MD, PhD, Professor and Chairman of the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center, recently chaired i3 Health’s CME/NCPD/AAPA activity, "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes." With numerous new developments in melanoma treatment over recent months, Dr. Davies sat down again to share these critical updates that are impacting practice. After the interview, stay tuned to hear module 2 of the full podcast activity.
Click the link to complete module 2 and claim your free credit: https://bit.ly/44yO9RB
View all episodes
By i3 HealthThe treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies, MD, PhD, Professor and Chairman of the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center, recently chaired i3 Health’s CME/NCPD/AAPA activity, "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes." With numerous new developments in melanoma treatment over recent months, Dr. Davies sat down again to share these critical updates that are impacting practice. After the interview, stay tuned to hear module 2 of the full podcast activity.
Click the link to complete module 2 and claim your free credit: https://bit.ly/44yO9RB